Davidian, Marie.
Marie Davidian American biostatistician
Davidian, Marie, 19..-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 6368492 (Personal)
Permalink: http://viaf.org/viaf/6368492
Preferred Forms
-
100 1 _ ‡a Davidian, Marie
-
100 1 _ ‡a Davidian, Marie
-
100 1 _ ‡a Davidian, Marie
-
100 1 _
‡a
Davidian, Marie
-
100 1 _ ‡a Davidian, Marie
-
100 1 _ ‡a Davidian, Marie
-
100 1 _
‡a
Davidian, Marie
-
100 1 _
‡a
Davidian, Marie
-
100 1 _
‡a
Davidian, Marie,
‡d
19..-....
-
100 1 _ ‡a Davidian, Marie.
-
100 0 _
‡a
Marie Davidian
‡c
American biostatistician
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| The analysis of multivariate longitudinal data: a review |
|
| Assessing the causal effect of organ transplantation on the distribution of residual lifetime. |
|
| Biometrics. Report of the editors--2011 |
|
| Collaboration To Meet the Statistical Needs in the Chemistry Curriculum |
|
| Conditional estimation for generalized linear models when covariates are subject-specific parameters in a mixed model for longitudinal measurements |
|
| Demographic and historical findings, including exposure to environmental tobacco smoke, in dogs with chronic cough. |
|
| Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods |
|
| Discussion of "Combining biomarkers to optimize patient treatment recommendation". |
|
| Discussion of "Connections Between Survey Calibration Estimators and Semiparametric Models for Incomplete Data" by T. Lumley, P.A. Shaw & J.Y. Dai. |
|
| Dynamic treatment regimes, 2020: |
|
| Estimating weights in heteroscedastic regression models ... 1985: |
|
| Estimation After a Group Sequential Trial |
|
| Estimation of optimal treatment regimes with electronic medical record data using the residual life value estimator |
|
| Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials |
|
| An estimator for the proportional hazards model with multiple longitudinal covariates measured with error |
|
| Gene-trait similarity regression for multimarker-based association analysis. |
|
| Improved doubly robust estimation when data are monotonely coarsened, with application to longitudinal studies with dropout |
|
| Improving efficiency and robustness of the doubly robust estimator for a population mean with incomplete data |
|
| Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial |
|
| The International Year of Statistics: A Celebration and A Call to Action |
|
| Likelihood and Pseudo-likelihood Methods for Semiparametric Joint Models for a Primary Endpoint and Longitudinal Data |
|
| Longitudinal data analysis / ed by Garret Fitzmaurice, Marie Davidian, Geert Verbeke. - Boca Raton, 2008. |
|
| Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology |
|
| Mixed model analysis of censored longitudinal data with flexible random-effects density |
|
| Moment Adjusted Imputation for Multivariate Measurement Error Data with Applications to Logistic Regression |
|
| Nonlinear models for repeated measurement data |
|
| On Estimation of Optimal Treatment Regimes For Maximizing t-Year Survival Probability. |
|
| On random sample size, ignorability, ancillarity, completeness, separability, and degeneracy: sequential trials, random sample sizes, and missing data |
|
| Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMART. |
|
| A Placebo-Controlled, Prospective, Randomized Clinical Trial of Polyethylene Glycol and Methylprednisolone Sodium Succinate in Dogs with Intervertebral Disk Herniation |
|
| Properties of Estimators in Exponential Family Settings with Observation-based Stopping Rules |
|
| Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reop |
|
| Robust two-stage approach to repeated measurements analysis of chronic ozone exposure in rats |
|
| Semiparametric Estimation of Treatment Effect in a Pretest-Posttest Study with Missing Data |
|
| 'Smooth' inference for survival functions with arbitrarily censored data |
|
| Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine |
|
| "Smooth" semiparametric regression analysis for arbitrarily censored time-to-event data |
|
| Smoothing spline-based score tests for proportional hazards models |
|
| SNP_NLMM: A SAS Macro to Implement a Flexible Random Effects Density for Generalized Linear and Nonlinear Mixed Models |
|
| Special Issue of Journal of Biopharmaceutical Statistics dedicated to 2016 Trends and Innovations in Clinical Trial Statistics (TICTS) Conference. |
|
| Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study |
|
| Surgeons' economic profiles: can we get the "right" answers? |
|
| Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation |
|
| Ten Simple Rules for Effective Statistical Practice |
|
| Testing homogeneity of intra-run variance parameters in immunoassay |
|
| Using decision lists to construct interpretable and parsimonious treatment regimes. |
|
| Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection |
|
| Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategy |
|
| Variable selection for covariate-adjusted semiparametric inference in randomized clinical trials. |
|
| Why statistics? |
|
| The work of Raymond J. Carroll the impact and influence of a statistician |
|
